BACKGROUND: Invasive group A Streptococcus (GAS) infections are associated with substantial morbidity and mortality. Recent national surveillance data report stable rates of invasive GAS disease, although these may not capture geographic variation. METHODS: We performed a population-based, retrospective laboratory surveillance study of invasive GAS disease among Utah residents from 2002-2010. We used Intermountain Healthcare's electronic medical records and data warehouse to identify patients from whom GAS was isolated by culture. We defined clinical syndromes of invasive GAS disease on the basis of International Classification of Diseases, Ninth Revision codes. We abstracted demographic information, comorbidities, and microbiologic and laboratory findings. RESULTS: From 2002-2010, we identified 1514 cases of invasive GAS disease among Utah residents. The estimated mean annual incidence rate was 6.3 cases/100,000 persons, which was higher than the national rate of 3.6 cases/100,000 (P < .01). The incidence of invasive GAS disease in Utah rose from 3.5 cases/100,000 persons in 2002 to 9.8 cases/100,000 persons in 2010 (P = .01). Among children aged <18 years, the incidence of invasive GAS increased from 3.0 cases/100,000 children in 2002 to 14.1 cases/100,000 children in 2010 (P < .01). The increase in the pediatric population was due, in part, to an increase in GAS pneumonia (P = .047). The rate of invasive GAS disease in adults aged 18-64 years increased from 3.4 cases/100 000 persons in 2002 to 7.6 cases/100,000 persons in 2010 (P = .02). Rates among those aged ≥65 years were stable. The incidence of acute rheumatic fever declined from 6.1 to 3.7 cases/100,000 (P = .04). CONCLUSIONS: The epidemiologic characteristics of invasive GAS disease in Utah has changed substantially over the past decade, including a significant increase in the overall incidence of invasive disease-driven primarily by increasing disease in younger persons-that coincided temporally with a decrease in the incidence of acute rheumatic fever.
BACKGROUND: Invasive group A Streptococcus (GAS) infections are associated with substantial morbidity and mortality. Recent national surveillance data report stable rates of invasive GAS disease, although these may not capture geographic variation. METHODS: We performed a population-based, retrospective laboratory surveillance study of invasive GAS disease among Utah residents from 2002-2010. We used Intermountain Healthcare's electronic medical records and data warehouse to identify patients from whom GAS was isolated by culture. We defined clinical syndromes of invasive GAS disease on the basis of International Classification of Diseases, Ninth Revision codes. We abstracted demographic information, comorbidities, and microbiologic and laboratory findings. RESULTS: From 2002-2010, we identified 1514 cases of invasive GAS disease among Utah residents. The estimated mean annual incidence rate was 6.3 cases/100,000 persons, which was higher than the national rate of 3.6 cases/100,000 (P < .01). The incidence of invasive GAS disease in Utah rose from 3.5 cases/100,000 persons in 2002 to 9.8 cases/100,000 persons in 2010 (P = .01). Among children aged <18 years, the incidence of invasive GAS increased from 3.0 cases/100,000 children in 2002 to 14.1 cases/100,000 children in 2010 (P < .01). The increase in the pediatric population was due, in part, to an increase in GAS pneumonia (P = .047). The rate of invasive GAS disease in adults aged 18-64 years increased from 3.4 cases/100 000 persons in 2002 to 7.6 cases/100,000 persons in 2010 (P = .02). Rates among those aged ≥65 years were stable. The incidence of acute rheumatic fever declined from 6.1 to 3.7 cases/100,000 (P = .04). CONCLUSIONS: The epidemiologic characteristics of invasive GAS disease in Utah has changed substantially over the past decade, including a significant increase in the overall incidence of invasive disease-driven primarily by increasing disease in younger persons-that coincided temporally with a decrease in the incidence of acute rheumatic fever.
Authors: Katherine L O'Brien; Bernard Beall; Nancy L Barrett; Paul R Cieslak; Arthur Reingold; Monica M Farley; Richard Danila; Elizabeth R Zell; Richard Facklam; Benjamin Schwartz; Anne Schuchat Journal: Clin Infect Dis Date: 2002-07-10 Impact factor: 9.079
Authors: L George Veasy; Lloyd Y Tani; Judy A Daly; Kent Korgenski; Lonnie Miner; James Bale; Edward L Kaplan; James M Musser; Harry R Hill Journal: Pediatrics Date: 2004-03 Impact factor: 7.124
Authors: A Lepoutre; A Doloy; P Bidet; A Leblond; A Perrocheau; E Bingen; P Trieu-Cuot; A Bouvet; C Poyart; D Lévy-Bruhl Journal: J Clin Microbiol Date: 2011-10-05 Impact factor: 5.948
Authors: L G Veasy; S E Wiedmeier; G S Orsmond; H D Ruttenberg; M M Boucek; S J Roth; V F Tait; J A Thompson; J A Daly; E L Kaplan Journal: N Engl J Med Date: 1987-02-19 Impact factor: 91.245
Authors: Stephanie H Factor; Orin S Levine; Benjamin Schwartz; Lee H Harrison; Monica M Farley; Allison McGeer; Anne Schuchat Journal: Emerg Infect Dis Date: 2003-08 Impact factor: 6.883
Authors: Yuan Li; Joy Rivers; Saundra Mathis; Zhongya Li; Srinivasan Velusamy; Srinivas A Nanduri; Chris A Van Beneden; Paula Snippes-Vagnone; Ruth Lynfield; Lesley McGee; Sopio Chochua; Benjamin J Metcalf; Bernard Beall Journal: Front Microbiol Date: 2020-07-24 Impact factor: 5.640
Authors: Emma Sherwood; Stefania Vergnano; Isona Kakuchi; Michael G Bruce; Suman Chaurasia; Samara David; Angela Dramowski; Scarlett Georges; Rebecca Guy; Theresa Lamagni; Daniel Levy-Bruhl; Outi Lyytikäinen; Monika Naus; Jennifer Onukwube Okaro; Oddvar Oppegaard; Didrik F Vestrheim; Tammy Zulz; Andrew C Steer; Chris A Van Beneden; Anna C Seale Journal: Lancet Infect Dis Date: 2022-04-04 Impact factor: 71.421
Authors: Shu Ki Tsoi; Pierre R Smeesters; Hannah R C Frost; Paul Licciardi; Andrew C Steer Journal: J Immunol Res Date: 2015-05-25 Impact factor: 4.818
Authors: Fawzyh J Al-Khadidi; Mohammed A AlSheheri; Tariq S AlFawaz; Mushira A Enani; Abdulaziz A AlAqeel; Dayel A AlShahrani Journal: Saudi Med J Date: 2017-10 Impact factor: 1.484